Similar articles

• Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.

  Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, Miletić A, Nalbandyan K, Cerwenka A, Jonjic S, Mandelboim O, Porgador A. Yossef R, et al. PLoS One. 2015 Feb 26;10(2):e0118936. doi: 10.1371/journal.pone.0118936. eCollection 2015. PLoS One. 2015. PMID: 25719382 Free PMC article.
• The activating receptor NKp46 is essential for the development of type 1 diabetes.

  Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O. Gur C, et al. Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20. Nat Immunol. 2010. PMID: 20023661
• Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46.

  Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, Stolovich-Rain M, Nir T, Achdout H, Glaser B, Shapiro J, Naparstek Y, Porgador A, Dor Y, Mandelboim O. Gur C, et al. J Immunol. 2011 Sep 15;187(6):3096-103. doi: 10.4049/jimmunol.1101269. Epub 2011 Aug 17. J Immunol. 2011. PMID: 21849674
• Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.

  Koch J, Steinle A, Watzl C, Mandelboim O. Koch J, et al. Trends Immunol. 2013 Apr;34(4):182-91. doi: 10.1016/j.it.2013.01.003. Epub 2013 Feb 13. Trends Immunol. 2013. PMID: 23414611 Review.
• Interferon alpha: The key trigger of type 1 diabetes.

  Lombardi A, Tsomos E, Hammerstad SS, Tomer Y. Lombardi A, et al. J Autoimmun. 2018 Nov;94:7-15. doi: 10.1016/j.jaut.2018.08.003. Epub 2018 Aug 14. J Autoimmun. 2018. PMID: 30115527 Free PMC article. Review.